Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Berman

Dermatology Aventura, FL Medical Doctor

NPI 1255316352 CMS profile 11666

2925 Aventura Boulevard, S. 205, Aventura, FL 33180

Open in the dashboard

General payments

$404,673

398 records reported · program years 2019–2025

Research payments

$3,200

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$26,626 paid to institutions, not to them · program years 2019–2020

Through program year 2025, Brian Berman of Aventura, FL is reported in the CMS Open Payments database as having received $404,673 across 398 general payments and $3,200 in research payments paid to them. Separately, studies naming them as principal investigator received $26,626 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $42,156 46
2024 General $40,918 59
2023 General $66,808 72
2023 Research $3,200 1
2022 General $65,221 57
2021 General $46,545 43
2020 General $50,254 31
2019 General $92,772 90

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Berman
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Brian Berman were reported at $42,156. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Brian Berman Dermatology median Middle half National median
2019 $92,772 $454 $129–$1,240 $163
2020 $50,254 $235 $81–$756 $114
2021 $46,545 $377 $108–$1,108 $132
2022 $65,221 $514 $143–$1,391 $149
2023 $66,808 $607 $159–$1,674 $160
2024 $40,918 $751 $204–$1,903 $164
2025 $42,156 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Almirall LLC $157,430 118 payments
  2. Novartis Pharmaceuticals Corporation $61,847 56 payments
  3. Sun Pharmaceutical Industries Inc. $50,328 51 payments
  4. Sensus Healthcare, Inc. $29,655 2 payments
  5. LEO Pharma Inc. $20,534 11 payments
  6. Dermira, Inc. $16,292 23 payments
  7. Pfizer Inc. $11,724 8 payments
  8. E.R. Squibb & Sons, L.L.C. $7,529 11 payments
  9. LNHC, Inc $7,126 8 payments
  10. EPI Health, LLC $6,805 13 payments
  11. Other $35,403 97 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $240,783 81 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $70,719 23 payments
  3. Honoraria $53,200 11 payments
  4. Travel and Lodging $23,529 69 payments
  5. Food and Beverage $16,423 213 payments
  6. Education $19 1 payment
Products named General payments · program years 2019–2025
  1. Klisyri $137,375 89 payments
  2. Odomzo $29,247 29 payments
  3. LEVULAN KERASTICK $19,828 18 payments
  4. QBREXZA $15,910 19 payments
  5. Seysara $15,841 8 payments
  6. PICATO $14,290 6 payments
  7. LIBTAYO $11,548 9 payments
  8. PIQRAY $11,160 3 payments
  9. COSENTYX $11,094 13 payments
  10. BLU-U $10,140 11 payments
  11. Other $79,377 181 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Pfizer Inc. $3,200 1 payment

Records

399 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record